表紙
市場調查報告書
商品編碼
961520

全球神經血管裝置市場:2020-2027

Global Neurovascular Devices Market - 2022-2029

出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

老年人口的迅速增加是市場增長的主要動力。此外,諸如神經血管疾病的流行和全球範圍內神經血管設備的採用激增等因素也推動了市場的增長。另外,與神經血管裝置有關的技術進步的迅速擴展正在驅動神經血管裝置市場的增長。

然而,全世界除COVID-19以外的其他疾病的藥物供應有限,對神經血管設備市場產生了負面影響。此外,全球醫護人員數量有限也是阻礙預測期內市場增長的一個因素。

本報告調查了全球神經血管裝置市場,並提供了系統信息,例如市場概況,按細分市場和地區劃分的市場規模預測,主要公司的概況以及競爭條件的分析。

目錄

第1章全球神經血管設備市場:調查方法/範圍

  • 調查方法
  • 調查目的/範圍

第2章全球神經血管設備市場:市場定義/概述

第3章全球神經血管設備市場:執行摘要

  • 市場細分:按產品
  • 市場細分:按疾病
  • 市場細分:按地區

第4章全球神經血管設備市場:市場動態

  • 市場影響因素
    • 促進因素
    • 抑制因素
  • 影響分析
  • 市場機會

第5章全球神經血管設備市場:行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 監管分析
  • 價格分析
  • 產品分析
  • 售後服務分析

第6章全球神經血管設備市場:按產品

  • 簡介
  • 市場規模分析/同比增長率分析:按產品
  • 市場吸引力指數:按產品
    • 動脈瘤線圈和栓塞器
    • 腦動脈球囊血管生成/支架系統
    • 支撐裝置
    • 神經節切除器
    • 其他

第7章全球神經血管設備市場:按疾病分類

  • 簡介
  • 市場規模分析/同比增長率分析:按疾病
  • 市場吸引力指數:按疾病分類
    • 動脈瘤
    • 缺血性中風
    • 腦動脈瘤
    • 動靜脈畸形/動靜脈瘺
    • 其他

第8章全球神經血管設備市場:按地區

  • 簡介
  • 市場規模分析/同比增長率分析:按地區
  • 市場吸引力指數:按地區
  • 北美
    • 簡介
    • 特定地區的主要動態
    • 市場規模分析/同比增長率分析:按產品
    • 市場規模分析/同比增長率分析:按疾病
    • 市場規模分析/同比增長率分析:按國家
  • 歐洲
  • 南美洲
  • 亞太地區
  • 中東/非洲

第9章全球神經血管設備市場:競爭狀況

  • 競爭情景
  • 市場定位/佔有率分析
  • 併購分析

第10章公司簡介

  • American Esoteric Laboratories
    • 公司簡介
    • 投資組合/說明
    • 主要亮點
    • 財務概覽
  • Johnson & Johnson
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
  • Merit Medical Systems, Inc.
  • Integer Holdings Corporation

第11章全球神經血管設備市場:重要考慮因素

第12章全球神經血管設備市場:DataM

  • 附錄
  • 關於我們的公司和服務
  • 聯繫我們
目錄
Product Code: DMMD2674

Market Overview

The Global Neurovascular Devices Market is expected to grow at a high CAGR of 4.3% during the forecasting period (2022-2029).

Neurovascular devices are employed in the treatment of neurovascular disorders. Neurovascular diseases affect the cerebral vascular system and the spinal cord that encompasses any abnormality of the blood vessels within or supplying the brain and spine. Abnormalities may be narrowing of arteries which reduces blood flow to the brain which leads to a risk of stroke and weakening of arteries which leads to brain aneurysms and increase the risk of intracranial bleeding.

Market Dynamics

The global neurovascular devices market growth is driven by the increasing target patient population, ongoing product development and commercialization, and rising research activities in the field of neurovascular therapies.

The increasing R&D investments in the pharmaceutical and biotechnology industry will drive the market growth

Neurosurgeons and medical professionals are increasingly looking at therapeutic alternatives that can effectively reduce the risk of fatality or severity of neurovascular diseases in patients. With a growing number of patients suffering from neurovascular diseases (such as epilepsy, brain stroke, and cerebral aneurysm) and rising severity of medical conditions (such as hemorrhage and local infections) in target patients, the demand for effective neurovascular treatments is continuously rising across key markets such as the US, Germany, Japan, China, and India. For instance, a cerebral aneurysm is a common neurovascular disorder across the globe. This condition has a significant risk of hemorrhage or permanent neurological damage associated with it. As of 2020, 6.5 million brain aneurysm cases were reported in the US and 30,000 people in the US suffer brain aneurysm rupture every year.

According to the NHS England, around 1 in 12,500 people in England have a brain aneurysm every year. Furthermore, around 3% of adults in the U.K. have a cerebral aneurysm. The increasing prevalence of hypertension, alcohol consumption, and smoking is anticipated to result in a brain aneurysm. The advancement of innovative technology has led to significant demand for procedures with minimum invasion. Slightly invasive procedures offering benefits to the patients including decreased pain, less blood loss, and cost-effectiveness will increase the adoption of neurovascular surgeries, these factors will also help to accelerate neurovascular devices market growth in the forecast period.

Stringent regulations will hamper the growth of the market

Several key neurovascular device manufacturers (such as Stryker and Medtronic Plc) have been successful in the development and subsequent commercialization of their respective products during the last decade. These products were primarily intended for interventional use during neurovascular surgeries. However, across the mature markets (particularly in the US), the developmental pipeline for interventional neurology products is affected mainly by pricing pressure faced by the key product manufacturers as a result of unsupportive government reforms undertaken in the last three years. Regulatory laws in the US require substantial scientific evidence for clinical trials conducted on human subjects to confirm the safety, efficacy, & risk profile of specific medical devices intended for a particular therapeutic application (including for neurovascular intervention). Thus, these factors will hamper the market growth in the forecast period.

COVID-19 Impact Analysis

COVID-19 impacted the global supply chain of medical devices, affecting the neurovascular devices market. Over the past two years, the number of patient visits to hospitals has also reduced significantly despite the emergency. There is considerable variation in the management of neurointerventional procedures during the COVID-19 pandemic. Patients are avoiding healthcare institutions to prevent contact with COVID-19 patients and healthcare professionals. Falling rates have been observed across a range of acute and critical conditions, including stroke, myocardial infarction, and various cancers. The interventional neurology devices market is expected to be impacted due to the temporary postponement of various elective surgeries, as governments and authorities seek to ensure the availability of resources for COVID-19 patients. Closed manufacturing facilities due to lockdowns have also disrupted supply chains, and reduced recruitments for clinical trials have further impacted the growth of the overall neurovascular devices market.

Segment Analysis

The ischemic strokes segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

Ischemic stroke is referred to as a heterogeneous multifactorial disease characterized by the sudden onset of neurologic signs that are directly related to the places of injury in the brain where the morbid process takes place. The evaluation of multifaceted neurologic disorders, including stroke, in which a large number of genetic and epigenetic factors interact with even the environmental risk factors in order to increase the risk has been revolutionized by the GWAS (genome-wide association studies) approach.

According to the Stroke Center, the US, the risk of ischemic stroke in current smokers is around two-fold higher than that of nonsmokers after fine-tuning with other risk factors. Hence, with the increasing smoking population, the prevalence of the disease is expected to rise significantly over the forecast period, thus contributing to the growth of the market in the forecast period.

Geographical Analysis

The North American region holds the largest market share of the global neurovascular devices market

North America dominates the market for Neurovascular Devices and is expected to show a similar trend over the forecast period, owing to the presence of a large number of key players operating in the neurovascular devices market. According to the Centers for Disease Control and Prevention (CDC) facts (2017), stroke results in the death of about 140,000 Americans each year which is 1 out of every 20 deaths. In the United States, there is estimated to be at least one stroke every 40 seconds, and every four minutes, someone dies of a stroke.

Approximately 87% of all strokes are ischemic strokes, in which blood flow to the brain gets blocked. Similarly, as stated by the Brain Aneurysm Foundation (2019), cerebral aneurysms affect an estimated 6 million Americans and are accountable for nearly half a million deaths worldwide each year, with half the victims age 50 and younger. All these factors are expected to fuel the overall market growth across the region. Thus, the presence of key players in the region leads to the easy availability of neurovascular devices. Moreover, other factors such as the surge in prevalence of neurovascular disorders are another major factor that boosts neurovascular devices market growth in the region.

Competitive Landscape

The neurovascular devices market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Abbott Laboratories, Johnson & Johnson (DePuy Synthes), Medtronic plc, MicroPort Scientific Corporation, Penumbra, Inc., Stryker Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., Asahi Intecc Co. Ltd, and Acandis GmbH among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the neurovascular devices market globally. For instance, in 2021, Pehnox established a new entity in the UK in light of Brexit to strengthen its footprint in the key markets across Europe.

Medtronic plc

Overview:

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical-Surgical Portfolio, and Diabetes Operating Unit.

Product Portfolio:

SOLITAIRE X: The Solitaire X Revascularization Device, featuring Parametric design, a unique overlapping stent retriever-based technology, restores blood flow and retrieves clots from occluded blood vessels in the brain for patients experiencing acute ischemic stroke (AIS) due to a large vessel occlusion (LVO).

Why Purchase the Report?

Visualize the composition of the global neurovascular devices market segmentation by product, disease, and region highlighting the key commercial assets and players.

Identify commercial opportunities in the global neurovascular devices market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global neurovascular devices market-level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global neurovascular devices market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 195 pages.

Table of Contents

1. Global Neurovascular Devices Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Neurovascular Devices Market -Market Definition and Overview

3. Global Neurovascular Devices Market - Executive Summary

  • 3.1. Market Snippet By Product
  • 3.2. Market Snippet By Disease
  • 3.3. Market Snippet by Region

4. Global Neurovascular Devices Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The increasing R&D investments in the pharmaceutical and biotechnology industry
      • 4.1.1.2. Increasing Target Patient Population
    • 4.1.2. Restraints:
      • 4.1.2.1. Stringent regulations will hamper
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Neurovascular Devices Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. Global Neurovascular Devices Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. Global Neurovascular Devices Market - By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
    • 7.1.2. Market Attractiveness Index, By Product Segment
  • 7.2. Aneurysm Coiling & Embolization Devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Cerebral Balloon Angioplasty and Stenting Systems
  • 7.4. Support Devices
  • 7.5. Neurothrombectomy Devices
  • 7.6. Other

8. Global Neurovascular Devices Market - By Disease

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
    • 8.1.2. Market Attractiveness Index, By Disease Segment
  • 8.2. Aneurysm*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Ischemic Strokes
  • 8.4. Cerebral Aneurysms
  • 8.5. Arteriovenous Malformation and Fistulas
  • 8.6. Other

9. Global Neurovascular Devices Market - By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. The U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease

10. Global Neurovascular Devices Market - Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Benchmarking

11. Global Neurovascular Devices Market - Company Profiles

  • 11.1. Abbott Laboratories*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Johnson & Johnson (DePuy Synthes)
  • 11.3. Medtronic plc
  • 11.4. MicroPort Scientific Corporation
  • 11.5. Penumbra, Inc.
  • 11.6. Stryker Corporation
  • 11.7. Terumo Corporation
  • 11.8. W. L. Gore & Associates, Inc.
  • 11.9. Asahi Intecc Co. Ltd
  • 11.10. Acandis GmbH

LIST NOT EXHAUSTIVE

12. Global Neurovascular Devices Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us